Can Eye Drops Cure Cataracts And Macular Degeneration? C-KAD OS And CAN-C Drops In Trials And On Market – Acetylcarnosine
(Best Syndication) Pinon Hills CA – New information is available for people with cataracts and who are considering cataract surgery. An over the counter (OCT) eye drop may prevent and cure cataracts, according to Russian and American researchers. The drops may not say anything about cataracts on box, but they contain 1% n- N-Acetyl Carnosine (NAC).
The eyedrops are designed for soothing red and irritated eyes. According to Thomas M. Sipos in The Weekly Universe, acetylcarnosine is not approved by the FDA and for this reason, companies selling it are “wary of making claims for its being a cataract cure.” The drops can be sold without a prescription.
Sipos says there is no patent on the substance and several companies are offering it in the US; and because of market competition the price is low. NAC is also claimed to be an inactive ingredient on the label.
According to Corey Binns of Popular Science Magazine, the breakthrough came when Rajiv Bhushan’s father was diagnosed with cataracts. Bhushan is an electrical engineer who set out to concoct a chemical solution to break up the molecules that were clouding the vision.
The most common treatment for cataract is surgery, but there can be complications. Right now Bhushan’s company, Chakshu Research, is working on eye drops called C-KAD, which is undergoing clinical trials right now.
The company has high hopes that “C-KAD Ophthalmic Solution (C-KAD OS), to reduce and repair oxidative damage which has been implicated in blinding degenerative diseases such as cataract, glaucoma, dry AMD, diabetic retinopathy.”
In an interview posted on antiaging-systems.com, Mark Babizhayev Ph.D. says there are tests underway in Russia. Babizhayev is one of the principal Russian researchers behind the development of NAC eye-drops.
Before testing the drops on humans, the Russian scientists developed some sensitive equipment to make the measurements. Statistical analysis revealed significant differences between 6 and 24 months as an overall cumulative and positive change of the characteristics of cataracts in the NAC-treated group, when compared to the control group.
So how do the CAN-C eye-drops work? Babizhavev says "The therapeutical indication for NAC to treat senile cataract can lead to diminishing of light-scattering units in the lens, probably by prevention of the oxidative modification of crystallins and utilization of lipid peroxides that promote lens opacities.”
By Dan Wilson
Best Syndication News Writer